Market News & Trends
Aurin Biotech Awarded US Patent for Cancer Drug
Aurin Biotech’s ATAC, a drug which has successfully halted the growth of cancerous tumors, was recently awarded a patent (10,004,707 B2) by the United States…
Catalent Biologics Adopts Berkeley Lights’ Beacon Optofluidic Platform
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer health products, and Berkeley Lights, Inc.…
Axovant Announces Global Licensing Agreement With Benitec Biopharma
Axovant Sciences recently announced it has licensed exclusive global rights to an investigational Silence-and-Replace gene therapy program from Benitec Biopharma for the treatment of oculopharyngeal…
Zynerba Pharmaceuticals Initiates CONNECT-FX, a Pivotal Clinical Trial
Zynerba Pharmaceuticals, Inc. recently announced the initiation of a multi-national, randomized, double blind placebo controlled Clinical study of Cannabidiol (CBD) in Children and Adolescents with…
Endocyte & ITM Announce Long-Term Supply Agreement
Endocyte, Inc. and ITM Isotopen Technologien München AG recently announced that ITM´s subsidiary, Isotope Technologies Garching GmbH (ITG), and Endocyte have signed a long-term global…
iBio Establishes Strategic Commercial Relationship with CC-Pharming Ltd.
iBio, Inc. recently announced the commencement of a strategic commercial relationship with CC-Pharming Ltd. of Beijing, China for joint development of products and manufacturing facilities…
Codexis Doses First Subjects in Phase 1a Trial; Triggers Milestone
Codexis, Inc. recently announced it has dosed the first subjects in a first-in-human Phase 1a dose-escalation trial with CDX-6114, its orally administered enzyme therapeutic being…
Eisai & Biogen Announce Positive Topline Results
Eisai Co., Ltd. and Biogen Inc. recently announced positive topline results from the Phase II study with BAN2401, an anti-amyloid beta protofibril antibody, in 856…
Integrated Partnerships Paired With Innovative Approaches Are a Key to Success
As we come to learn more about the human body, the dynamics of the industry must react accordingly. A primary example of this is the fact that the dominating blockbuster drug model that was paramount in the industry until a couple of years ago is no longer valid……
Pfenex Receives Milestone From Merck
Pfenex Inc. recently announced the receipt of a milestone payment from Merck associated with the initiation of the first Phase 3 clinical study of (V114), an investigational polyvalent conjugate vaccine for the prevention of pneumococcal disease.
Immatics Enters Strategic Partnership With Genmab
Immatics Biotechnologies GmbH recently announced it has entered into a research collaboration and license agreement with Genmab A/S to develop next-generation, T-cell engaging bispecific immunotherapies targeting multiple cancer indications.
Gerresheimer Acquires Sensile Medical
With the acquisition of Sensile Medical AG, Switzerland under a recent share purchase agreement, Gerresheimer is extending its business model in the direction of an Original Equipment Manufacturer (OEM) for drug delivery platforms with digital and electronic capabilities for pharmaceutical and biopharmaceutical customers.
BioCanCell Announces Completion of $23-Million Financing
BioCanCell Ltd. recently announced it has completed a $22.9-million PIPE financing round. The financing was led by Shavit Capital, with investors from the US, Israel, and…
Immutep Submits IND Application With FDA
Immutep Limited recently announced it has submitted its Investigational New Drug (IND) application to the US FDA for eftilagimod alpha (efti or IMP321) in June…
Conatus Pharmaceuticals’ Pan-Caspase Inhibitor Emricasan Improves Survival & Portal Hypertension
Conatus Pharmaceuticals Inc. recently announced the publication of results from preclinical studies of its pan-caspase inhibitor emricasan, demonstrating improvements in portal hypertension (elevated blood pressure…
Catalent Signs Agreement to Acquire Juniper Pharmaceuticals
Catalent, Inc. recently announced it has agreed to acquire Juniper Pharmaceuticals, Inc., including its Nottingham, U.K.-based Juniper Pharma Services division. When combined with Catalent’s existing…
BASi & Seventh Wave Laboratories Combine Operations to Provide Broader Solutions & Greater Scientific Expertise to Clients
Bioanalytical Systems, Inc. and Seventh Wave Laboratories, LLC, recently announced they have signed an asset purchase agreement (APA) joining operations to provide broader solutions and…
ASLAN Pharmaceuticals Submits Clinical Trial Authorization Application
ASLAN Pharmaceuticals recently announced the submission of a clinical trial authorization application with the Singapore Health Sciences Authority (HSA) to initiate a Phase 1 trial…
Biologic Excipients Market Expected to be Valued at $1.7 Billion by End of 2028
Future Market Insights (FMI) delivers key insights on the global biologic excipients market in its upcoming report titled Biologic Excipients Market: Global Industry Analysis 2013–2017 and Opportunity Assessment…
Lonza Launches New Bioscience Website
Lonza Bioscience is inviting visitors to explore its new dedicated website: bioscience.lonza.com.
